Journal
SEMINARS IN ONCOLOGY NURSING
Volume 36, Issue 1, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.soncn.2019.150983
Keywords
Chemotherapy-induced peripheral; Neuropathy; Neuropathic pain; Rehabilitation; Physical therapy modalities; Exercise
Funding
- American Cancer Society Denny Hoelzer Sentinel Technologies Doctoral Scholarship in Cancer Nursing [DSCN-17-082-01 - SCN]
- Mittelman Integrative Oncology Family Fund
- National Institute of Nursing Research, T32 [NR016914]
Ask authors/readers for more resources
Objective: To review assessment and management approaches for chemotherapy-induced peripheral neuropathy-related physical function deficits. Data Sources: Peer-reviewed articles from PubMed, Ovid MEDLINE, CINAHL PsycINFO, SPORTDiscus, Scopus, and key studies' reference lists. Conclusion: Brief clinical tests (eg, gait, Timed Up and Go) can screen for neuropathy-related physical function deficits. Exercise and physical therapy may be promising treatments, but the efficacy and optimal dose of such treatments for chemotherapy-induced peripheral neuropathy are unclear. Implications for Nursing Practice: Screening and assessment of neuropathy-associated physical function deficits should occur throughout neurotoxic chemotherapy treatment. If such deficits are identified, referral for rehabilitation (ie, physical or occupational therapy) and/or exercise interventions is warranted. (C) 2019 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available